MedPath

A clinical study on the increase of chemical substances which promote healing in humans and the presence of heavy metals in patients with liver disease caused by intake of homeopathic, allopathic, unani or siddha drugs

Not Applicable
Conditions
Health Condition 1: T479- Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the gastrointestinal system
Registration Number
CTRI/2018/03/012901
Lead Sponsor
Saara Banu EPM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients above 20 years with clinical symptoms of liver disease along with abnormal liver function test with History of intake of Complementary and Alternative Medicines or other drugs (prescribed drugs) for more than 2 months duration.

2.Both Male and female.

Exclusion Criteria

1.Chronic Alcoholic hepatitis patients, infective hepatitis A patients.

2.Age less than 20 years.

3.Pregnant women & lactating mothers.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath